Kristin Brandal
Papers
1
Total Citations
20
H-Index
1
About
Kristin Brandal is a leading molecular geneticist whose work has fundamentally advanced the diagnosis of heritable connective tissue disorders. Her primary research focuses on the genetic basis of Marfan syndrome (MFS) and related type-1 fibrillinopathies, with a particular emphasis on developing efficient mutation detection strategies for the notoriously complex *FBN1* gene. Her landmark 2006 paper, which has garnered 20 citations, introduced a groundbreaking protocol that combined automated sample preparation with direct sequencing as the primary diagnostic strategy. This work directly addressed the immense challenge of screening the *FBN1* gene’s 8,600-base-pair coding region across 65 exons, dramatically reducing the time and labor required for clinical testing. By streamlining the detection of the hundreds of known *FBN1* mutations, Brandal’s methodology has become a cornerstone in molecular diagnostics, enabling faster, more accurate diagnoses for patients and their families. Her contributions have not only improved clinical outcomes but also laid critical groundwork for future research into the pathophysiology of fibrillinopathies, cementing her reputation as a key innovator in the field of genetic testing.
Research Focus
Key Achievements
Top Papers
- 1